AngioDynamics (ANGO) Reports In-Line Q4 EPS ; Offers Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $12.64 +2.02%
Revenue Growth %: +0.0%
Financial Fact:
Research and development: 6.71M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +0.0%
Financial Fact:
Research and development: 6.71M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $91.1 million versus the consensus estimate of $90.74 million.
GUIDANCE:
AngioDynamics sees FY2024 EPS of $0.28-$0.34, versus the consensus of ($0.08). AngioDynamics sees FY2024 revenue of $328-333 million, versus the consensus of $323 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
- Ennis (EBF) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
